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4-3-3 proteins are phosphoserine/threonine-binding
proteins that play important roles in many regulatory
processes, including intracellular protein targeting.
14-3-3 proteins can anchor target proteins in the cyto-
plasm and in the nucleus or can mediate their nuclear
export. So far, no role for 14-3-3 in mediating nuclear
import has been described. There is also mounting evi-
dence that nuclear import is regulated by the phosphory-
lation of cargo proteins, but the underlying mechanism
remains elusive. Myopodin is a dual-compartment, actin-
bundling protein that functions as a tumor suppressor in
1
 
human bladder cancer. In muscle cells, myopodin redis-
tributes between the nucleus and the cytoplasm in a dif-
ferentiation-dependent and stress-induced fashion. We
show that importin 
 
 
 
 binding and the subsequent nuclear
import of myopodin are regulated by the serine/threo-
nine phosphorylation-dependent binding of myopodin to
14-3-3. These results establish a novel paradigm for the
promotion of nuclear import by 14-3-3 binding. They
provide a molecular explanation for the phosphorylation-
dependent nuclear import of nuclear localization signal-
containing cargo proteins.
 
Introduction
 
14-3-3 proteins are abundant, chaperone-like adaptor molecules
that act as homo- and heterodimers (Fu et al., 2000). Mono-
meric 14-3-3 consists of nine 
 
 
 
 helices, which create a COOH-
terminal binding cleft for target binding and an NH
 
2
 
-terminal
dimerization domain (Liu et al., 1995; Xiao et al., 1995). 14-3-3
proteins are predominately found in the cytoplasm (Dalal et al.,
1999; Kumagai and Dunphy, 1999; Muslin and Xing, 2000),
but are also found in the nucleus (Bihn et al., 1997; Todd et al.,
1998; Pan et al., 1999), in the Golgi apparatus (Celis et al.,
1990), and in chloroplasts (Sehnke et al., 2000). More than 100
14-3-3 interacting proteins have been identified. In most cases,
binding occurs through a consensus motif within the target
protein, which contains a phosphorylated serine or threonine
residue (sequence RSxpS/TxP; Muslin et al., 1996). 14-3-3
proteins have multiple effects on their targets, and the func-
tional variability is a feature of the binding partner rather than
an intrinsic 14-3-3 trait (Tzivion et al., 2001). 14-3-3 can regu-
late the subcellular localization of a binding partner. It may
cause the nuclear exclusion (Dalal et al., 1999; Kumagai and
Dunphy, 1999; Zhang et al., 1999; Grozinger and Schreiber,
2000; McKinsey et al., 2000; Wang et al., 2000; Cahill et al.,
2001; Brunet et al., 2002) or the nuclear (Seimiya et al., 2000)
or cytoplasmic retention (Dalal et al., 1999) of an interacting
protein. So far, no role for 14-3-3 in promoting the nuclear im-
port of a binding partner has been described.
Nuclear import is regulated at numerous levels, including
the posttranslational modification of cargo proteins. Phosphor-
ylation of some cargoes can mask their nuclear localization
signal (NLS), thereby abrogating their interaction with the cy-
toplasmic import receptor, importin 
 
 
 
, and blocking nuclear
import. Other cargo proteins show enhanced binding to impor-
tin 
 
 
 
 after phosphorylation, resulting in an increased nuclear
import rate (Jans et al., 2000). The mechanism underlying the
phosphorylation-dependent nuclear import of some NLS-
containing cargo proteins remains elusive. Phosphorylation
may directly modulate the affinity of the NLS for importin 
 
 
 
.
Alternatively, it may cause conformational changes within the
cargo or alter its binding to another protein, both of which may
reveal or mask the NLS (Harreman et al., 2004).
Myopodin is a dual-compartment, actin-bundling protein
that is found in the nucleus of undifferentiated myoblasts and at
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the Z-disc of differentiated myotubes, but it shuttles back to the
nucleus during thermal stress (Weins et al., 2001). In normal
bladder epithelium, myopodin is localized in the cytoplasm and
in the nucleus (Sanchez-Carbayo et al., 2003). Of note, the loss
of nuclear myopodin expression can predict the clinical out-
come of human progressive bladder cancer, implying that my-
opodin functions as a tumor suppressor (Sanchez-Carbayo et
al., 2003). The mechanism that regulates the subcellular local-
ization of myopodin is unknown. We describe a novel mecha-
nism for regulating the nuclear import of an NLS-containing
protein. We show that the phosphorylation-dependent binding
of 14-3-3 to myopodin is required for the interaction of myop-
odin with importin 
 
 
 
 and the subsequent nuclear import of myop-
odin. We discuss 14-3-3 binding as a novel, regulatory step that
promotes the nuclear import of cargo proteins.
 
Results
 
Myopodin is a novel 14-3-3–binding protein
 
Myopodin contains two classic nuclear localization signals, a
PPXY motif, an actin-binding site (Weins et al., 2001), and two
consensus 14-3-3–binding domains (Fig. 1 A). To identify my-
opodin-interacting proteins, we screened a mouse embryonic
cDNA library using the yeast two-hybrid system. Because full-
length myopodin was autoactive, we used the myopodin frag-
ment Myo-2 (aa 187–420) as bait (Fig. 1 A). Among several
others, we found a cDNA clone containing the COOH-terminal
part of 14-3-3
 
 
 
 (aa 143–246), which creates the binding cleft
of 14-3-3 (Fu et al., 2000).
 
Spatial and temporal co-distribution of 
myopodin and 14-3-3
 
 
 
In adult heart and skeletal muscles, myopodin is localized at
the Z-disc (Weins et al., 2001). By double labeling immunoflu-
orescence with the Z-disc marker 
 
 
 
-actinin, 14-3-3
 
 
 
 was also
found at the Z-disc of the heart (Fig. 1 B) and skeletal muscles
(unpublished data). Hence, both myopodin and 14-3-3
 
 
 
 are
components of the Z-disc. In undifferentiated C2C12 myo-
blasts, myopodin shows a predominantly nuclear localization
(Fig. 1 C, top; Weins et al., 2001), whereas 14-3-3
 
 
 
 is mainly
found in the cytoplasm (Fig. 1 C, top). This difference in the
subcellular localization of myopodin and 14-3-3
 
 
 
 seemed
Figure 1. Myopodin interacts with 14-3-3 via two con-
sensus 14-3-3–binding motifs. (A) Myopodin contains
two NLSs, a PPXY motif, two 14-3-3–binding motifs, and
an actin-binding site. Arrows indicate potential interac-
tions with other proteins or with protein domains (WW).
The Myo-2 fragment (aa 187–420) was used as bait in a
yeast two-hybrid screen. (B) 14-3-3  colocalizes with the
Z-disc marker  -actinin in mouse skeletal muscle. (C) In
undifferentiated C2C12 myoblasts, myopodin is predomi-
nantly found in the nucleus (top left), whereas 14-3-3  is
preferentially found in the cytoplasm (top right). Blocking
nuclear export with LMB does not affect the nuclear local-
ization of myopodin (bottom left), but leads to the nuclear
accumulation of 14-3-3  (bottom right). (D) Heat shock
causes nuclear accumulation of 14-3-3  in differentiated
myotubes, as visualized by double labeling with DAPI. (E)
Myopodin from mouse skeletal muscle (left) and C2C12
myoblast extracts (right) specifically binds to GST–14-3-3 ,
but not to GST alone. (F) Coimmunoprecipitation experi-
ments show that endogenous myopodin interacts with
14-3-3  in adult mouse heart. (left) IP with anti–14-3-3 ;
(right) IP with antimyopodin. No binding was found with
a control IgG. (G) Myopodin binds to all 14-3-3 isoforms
except 14-3-3 . 14-3-3  lacking the NH2-terminal dimer-
ization domain (  N) can bind to myopodin, albeit to a
lesser extent. In contrast, 14-3-3  carrying a point muta-
tion ( K49E) that is known to abrogate target binding
does not interact with myopodin. (H) The two consensus
14-3-3–binding motifs, 14-3-3#1 (sequence RSLASVP)
and 14-3-3#2 (sequence RSVTSP), were deleted sepa-
rately ( 14-3-3#1 and  14-3-3#2) and together ( 14-3-
3#1   2). Both FLAG– 14-3-3#1 and FLAG– 14-3-3#2
display dramatically reduced binding to 14-3-3  as com-
pared with full-length myopodin (full-length FLAG). Dele-
tion of both 14-3-3–binding motifs (FLAG– 14-3-3#1   2)
abrogates binding to 14-3-3 . 
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counterintuitive to the two-hybrid result and to the observed
biochemical interaction between both proteins (Fig. 1, E–H).
However, as shown for the U2OS osteosarcoma cell line, 14-3-3
 
 
 
is also localized in the cytoplasm but accumulates in the nu-
cleus after the blockage of nuclear export by leptomycin B
(LMB), implying that 14-3-3
 
 
 
 can shuttle between the cyto-
plasm and the nucleus (Brunet et al., 2002). Similarly, the in-
hibition of nuclear export with LMB for 90 min induced the
nuclear accumulation of 14-3-3
 
 
 
 (Fig. 1 C, bottom). We have
previously reported that after heat shock and LMB treatment,
myopodin relocates to the nucleus of differentiated myotubes,
showing that the nuclear export of myopodin is sensitive to
LMB (Weins et al., 2001). Here, we found that 14-3-3
 
 
 
 relo-
cates from the cytoplasm to the nucleus after heat shock (Fig.
1 D), suggesting that, similar to myopodin, the subcellular local-
ization of 14-3-3 is altered by cellular stress.
 
Endogenous myopodin specifically 
interacts with 14-3-3
 
 
 
 in myocytes
 
Myopodin specifically interacts with 14-3-3
 
 
 
 in GST pull-down
assays. GST–14-3-3
 
 
 
, but not GST alone, specifically bound to
myopodin from adult mouse skeletal muscle and C2C12 myo-
blast extracts (Fig. 1 E). To further confirm the interaction, en-
dogenous proteins were immunoprecipitated from mouse heart
extracts using an anti–14-3-3
 
 
 
 antibody and the myopodin-spe-
cific antibody SRIB2. Anti–14-3-3 precipitated 14-3-3
 
 
 
 from
the extract and also coprecipitated myopodin (Fig. 1 F, left).
Conversely, antimyopodin coimmunoprecipitated 14-3-3
 
 
 
 (Fig.
1 F, right). No interaction was found with a control IgG.
 
Myopodin interacts with all 14-3-3 
isoforms except 14-3-3
 
 
 
Mammals express seven different 14-3-3 isoforms (
 
 
 
, 
 
 
 
, 
 
 
 
, 
 
 
 
,
 
 
 
, 
 
 
 
, and 
 
 
 
; Fu et al., 2000), but the yeast two-hybrid screen had
identified only the 
 
 
 
 isoform as a myopodin-interacting pro-
tein. The binding of myopodin to other 14-3-3 isoforms was
tested in pull-down studies of GST–14-3-3 fusion proteins
and purified FLAG-myopodin (Fig. 1 G). Myopodin strongly
bound 14-3-3
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
 (Fig. 1 G). The interaction with
14-3-3
 
 
 
 and 
 
 
 
 was weaker, and no binding was found for 14-3-3
 
 
 
(Fig. 1 G). The K49E substitution in the binding groove of
14-3-3 causes the loss of target binding (Zhang et al., 1997),
and a 14-3-3
 
 
 
 K49E mutant also failed to bind to myopodin
(Fig. 1 G), confirming the specificity of the interaction. 14-3-3
dimerization is crucial for target protein binding and 14-3-3
functionality (Tzivion et al., 2001). Therefore, the requirement
of 14-3-3 dimerization for myopodin binding was tested with a
14-3-3
 
 
 
 construct (14-3-3
 
  
 
N) that lacked the NH
 
2
 
-terminal
dimerization domain (Seimiya et al., 2000). 14-3-3
 
  
 
N also
bound to FLAG-myopodin, but to a lesser extent than wild-
type 14-3-3
 
 
 
 (Fig. 1 G).
 
Two consensus 14-3-3 motifs mediate 
the binding of myopodin to 14-3-3
 
 
 
Myopodin contains two consensus 14-3-3–binding motifs (Fig.
1 H, top) that can mediate phosphorylation-dependent 14-3-3
binding (Yaffe et al., 1997). To map the 14-3-3
 
 
 
–binding sites
in myopodin, both motifs were deleted separately (
 
 
 
14-3-3#1
and 
 
 
 
14-3-3#2) or together (
 
 
 
14-3-3#1 
 
  
 
2; Fig. 1 H). Full-
length myopodin and deletion constructs were coexpressed
with GFP–14-3-3
 
 
 
 in HEK-293 cells and were analyzed by
coimmunoprecipitation. FLAG full-length myopodin showed a
strong interaction with GFP–14-3-3
 
 
 
, whereas a weak binding
was found for FLAG–
 
 
 
14-3-3#1 and FLAG–
 
 
 
14-3-3#2. No
binding to 14-3-3
 
 
 
 was found after the deletion of both motifs
(FLAG–
 
 
 
14-3-3#1 
 
  
 
2). Hence, myopodin contains two func-
tional 14-3-3–binding sites that mediate the interaction be-
tween myopodin and 14-3-3
 
 
 
.
 
14-3-3 function is required for the 
nuclear import of myopodin
 
14-3-3 proteins can regulate the subcellular localization of
binding partners (Muslin and Xing, 2000), and myopodin is a
dual-compartment protein (Weins et al., 2001). This raises the
possibility that 14-3-3
 
 
 
 participates in regulating the subcellu-
lar localization of myopodin. A dominant negative mutant of
14-3-3
 
 
 
 that lacks the NH
 
2
 
-terminal dimerization domain
(14-3-3
 
  
 
N) redistributes the catalytic subunit of human tel-
omerase from the nucleus to the cytoplasm (Seimiya et al.,
2000). Therefore, we tested the effect of 14-3-3
 
  
 
N (Fig. 1 G)
on the subcellular localization of myopodin in myoblasts. In
cells expressing GFP–14-3-3
 
  
 
N, myopodin showed a cyto-
plasmic localization (Fig. 2 A, bottom left), whereas in cells
expressing full-length GFP–14-3-3
 
 
 
 (Fig. 2 A, top left) or GFP
alone (not depicted), myopodin was localized in the nucleus.
 
14-3-3
 
 
 
 participates in the nuclear 
import of myopodin
At this point, two alternative mechanisms for the 14-3-3 –
mediated nuclear localization of myopodin were possible: (1)
14-3-3  binding facilitates nuclear import or (2) blocks the
LMB-sensitive (Weins et al., 2001) nuclear export of myopo-
din. To address this matter, we repeated the transfection studies
with the GFP–14-3-3  N construct in the presence of LMB
(Fig. 2 A, top). If 14-3-3  inhibits the nuclear export of myopo-
din, LMB should rescue GFP–14-3-3  N-transfected cells and
result in the nuclear relocalization of myopodin. In contrast, if
14-3-3  binding mediates the nuclear import of myopodin,
LMB should not affect the cytoplasmic localization of myopo-
din in cells expressing GFP–14-3-3  N. As shown in Fig. 2 A
(bottom right), myoblasts expressing GFP–14-3-3  N did not
show the nuclear localization of endogenous myopodin in the
presence of LMB, whereas in untransfected cells or in cells ex-
pressing GFP full-length 14-3-3  (Fig. 2 A, top right), myopo-
din was found in the nucleus. To test the activity of LMB, we
performed control experiments with transfected C2C12 myo-
blasts that expressed GFP–C19, the NH2-terminal fragment
(aa 1–276) of integrase interactor 1, which contain an LMB-sen-
sitive nuclear export signal (Craig et al., 2002). In untreated
cells, C19 was predominantly located in the cytoplasm and accu-
mulated in the nucleus after the inhibition of CRM1-mediated
export by LMB, thereby proving the activity of LMB under these
conditions (unpublished data). Together, these results suggest
that 14-3-3  is involved in the nuclear import of myopodin.JCB • VOLUME 169 • NUMBER 3 • 2005 418
Two NLSs and two 14-3-3–binding 
motifs are required for the nuclear 
import of myopodin
Myopodin contains two putative nuclear localization sequences:
NLS#1 and NLS#2 (Fig. 1 A). To assess the functionality of
these NLSs, we deleted them separately ( NLS#1 and
 NLS#2) or in combination ( NLS#1   2), and the subcellular
distribution was analyzed by confocal microscopy (Fig. 2 B). In
addition, myopodin-induced F-actin filaments (Weins et al.,
2001) were visualized with rhodamine-labeled phalloidin, and
nuclei were visualized with DAPI. GFP full-length myopodin
was mainly detected in the nucleus (Fig. 2 B). The quantitative
analysis showed that 73.4% of GFP full-length myopodin was
found in the nucleus, compared with 14.8% for  NLS#1 and
13.4% for  NLS#2 (Fig. 2 C). The simultaneous deletion of
both NLSs ( NLS#1   2) did not further decrease the amount
of nuclear myopodin (14.2%; Fig. 2 C). The differences be-
tween full-length myopodin and  NLS#1,  NLS #2, and  NLS
#1   2 were significant (P   0.01; t test). Hence, both NLSs of
myopodin are functional and necessary for an efficient nuclear
import of myopodin. However, even in the absence of both
NLSs,  14% of total GFP fusion protein is still found in the nu-
cleus, suggesting that other domains are also involved in the nu-
clear import of myopodin. To determine whether the observed
nuclear exclusion of myopodin in the presence of 14-3-3  N
(Fig. 2 A) resulted from a functional loss of the 14-3-3 –myop-
odin interaction, we next expressed myopodin deletion con-
structs that lacked the identified 14-3-3–binding motifs as GFP
fusion proteins in C2C12 myoblasts (Fig. 2 B). The deletion of
either one ( 14-3-3#1 and  14-3-3#2) or both ( 14-3-3#1   2)
14-3-3–binding motifs resulted in a dramatic decrease of nu-
clear myopodin. 20% of  14-3-3#1, 21.8% of  14-3-3#2, and
19.1% of  14-3-3#1   2 were localized in the nucleus (Fig. 2 C),
which is a significant difference from the 73.4% for full-length
myopodin (P   0.01; t test). Next, we examined whether 14-3-3 
can act synergistically with NLSs to maximize the efficacy of
nuclear import. Therefore, we created a GFP–myopodin con-
struct that lacked both 14-3-3–binding motifs and both NLSs
(Fig. 2 B,  14-3-3#1     2     NLS#1     2). GFP–myop-
odin 14-3-3#1   2    NLS#1   2 showed 6.4% nuclear lo-
calization (Fig. 2 C), which was significantly less when com-
pared with  NLS#1   2 or  14-3-3#1   2 (P   0.01; t test).
Together, both NLSs and both 14-3-3–binding sites are required
for the efficient nuclear import of myopodin.
The two 14-3-3 motifs are necessary for 
the binding of recombinant myopodin to 
endogenous 14-3-3  in myoblasts
To determine whether the various myopodin mutant forms
(Fig. 2 C) can bind to endogenous 14-3-3 , FLAG-tagged pro-
Figure 2. 14-3-3  is required for nuclear
import of myopodin. (A) Overexpression of
full-length GFP–14-3-3  does not change the
nuclear localization of endogenous myopodin
(top left), whereas the dominant negative form
GFP–14-3-3  N causes the nuclear exclusion
of myopodin (bottom left). LMB does not re-
verse the cytoplasmic localization of myopo-
din that is caused by GFP–14-3-3  N (bottom
right). (B) Confocal microscopy reveals a
predominantly nuclear localization of GFP-
tagged, full-length myopodin (top). Deletion of
both NLSs ( NLS#1     2) or both 14-3-3–
binding sites ( 14-3-3#1     2) dramatically
decreases the nuclear localization of GFP–
myopodin. The combined deletion of all four
binding motifs ( 14-3-3#1   2    NLS#1   2;
bottom) virtually abrogates the nuclear local-
ization of myopodin (bottom). (C) Quantitative
analysis is presented as a percentage of nu-
clear GFP–myopodin. 73.4% of GFP full-length
myopodin is found in the nucleus. Deletion of
both NLSs separately ( NLS#1 and  NLS#2)
or together ( NLS#1     2) decreases the
amount of nuclear GFP–myopodin to 14.8%,
13.4%, and 14.2%, respectively. Removal of
14-3-3–binding sites ( 14-3-3#1,  14-3-3#2,
and  14-3-3#1   2) reduces nuclear myopo-
din to 20.0%, 21.8%, and 19.1%, respec-
tively. Combined deletion of all four motifs
( 14-3-3#1   2    NLS#1   2) causes a
further reduction of nuclear myopodin to
6.4%. 60.5% of GFP (control) is found in the
nucleus. Statistical significance was confirmed
by analysis of variance between groups
(ANOVA; P    0.001). Error bars indicate
standard deviation.PROMOTION OF NUCLEAR IMPORT BY 14-3-3 • FAUL ET AL. 419
teins were expressed in C2C12 myoblasts and were immuno-
precipitated with anti-FLAG antibody (Fig. 3 A, bottom).
Similar to full-length myopodin (FLAG-full-length), FLAG–
 14-3-3#1 and FLAG- 14-3-3#2 coprecipitated endogenous
14-3-3 , albeit to a lesser extent (Fig. 3 A, top). In contrast,
FLAG- 14-3-3#1   2 did not bind to myopodin. These results
corroborate the interaction studies in transfected HEK-293
cells (Fig. 1 H) and suggest that binding to 14-3-3  is required
for the nuclear import of myopodin. The deletion of the two
NLSs separately (FLAG- NLS#1 and FLAG- NLS#2) or to-
gether (FLAG- NLS#1   2) did not abrogate the myopodin–
14-3-3  interaction. Therefore, the two NLSs in myopodin are
not necessary for its binding to 14-3-3 . As expected, FLAG–
 14-3-3#1   2    NLS#1   2 did not interact with endoge-
nous 14-3-3  (Fig. 3 A).
Removal of 14-3-3 motifs results in the 
loss of myopodin binding to importin  
Lysine-rich, classical NLSs (sequence K-K/R-X-K/R) that
were originally identified in the SV40 T antigen (Kalderon et
al., 1984; Lanford and Butel, 1984) are recognized by the im-
portin  /  dimer. Importin   directly binds to the basic NLSs
of cargo proteins but needs importin   to cross the nuclear pore
complex (Weis, 1998). To study the interaction between the
NLSs of myopodin and importin  , recombinant FLAG-myop-
odin proteins were analyzed for their ability to bind importin  
(Fig. 3 B). FLAG-myopodin proteins were expressed in HEK-
293 cells, were immunoprecipitated with anti-FLAG antibody,
and were incubated with total protein extract from Xenopus
laevis embryos. Eluates were analyzed with anti–14-3-3  (Fig.
3 B, top) or anti–importin   (Hachet et al., 2004; Fig. 3 B,
middle) antibodies. Immunolabeling with anti-FLAG anti-
body demonstrated that each binding reaction included equal
amounts of the various FLAG-tagged myopodin proteins (Fig.
3 B, bottom). Using full-length FLAG-myopodin, 14-3-3  and
importin    were coprecipitated, showing an interaction be-
tween myopodin and both proteins (Fig. 3 B). As shown for the
binding of endogenous 14-3-3  in myoblasts (Fig. 3 A), the de-
letion of the NLSs (FLAG- NLS#1, FLAG- NLS#2, and
FLAG- NLS#1   2) did not impair the myopodin–14-3-3 
interaction (Fig. 3 B). In contrast, FLAG- NLS#1   2 did not
bind importin  . The deletion of either NLS (FLAG- NLS#1
or FLAG- NLS#2) did not abrogate the interaction between
myopodin and importin   (Fig. 3 B). The removal of the two
14-3-3–binding domains, separately (FLAG- 14-3-3#1 and
FLAG- 14-3-3#2) or together (FLAG- 14-3-3#1     2), re-
sulted in the loss of the 14-3-3 and importin   binding (Fig. 3 B).
Hence, the presence of 14-3-3 motifs is necessary for the inter-
action of myopodin with importin  , whereas the two NLSs are
dispensable for the binding of myopodin to 14-3-3.
Inhibition of 14-3-3 binding with a high-
affinity peptide antagonist abrogates the 
interaction between myopodin and 
importin  
To further confirm this finding with another approach, the ex-
periment was repeated with full-length myopodin in the ab-
sence or presence of the R18 peptide, a well-established, high-
affinity competitive inhibitor of 14-3-3 binding (Wang et al.,
1999). R18 abolished the interaction between FLAG-myopodin
and endogenous 14-3-3  and between the binding of myopodin
and importin   (Fig. 3 C). This result lends further support to
our hypothesis that the binding of myopodin to importin   crit-
ically depends on the interaction of myopodin with 14-3-3.
The direct binding of myopodin to importin   
requires the presence of 14-3-3
To determine whether myopodin can directly bind to importin  ,
we conducted in vitro reconstitution studies with purified impor-
tin  , myopodin, and 14-3-3 . To do so, purified GST-tagged
importin   was incubated with purified, FLAG-tagged myopo-
din, FLAG-tagged 14-3-3 , or both together and analyzed by
GST pull-down studies (Fig. 3 D). When importin   was incu-
bated with myopodin (Fig. 3 D, left) or 14-3-3  (Fig. 3 D, mid-
dle) alone, no interaction was found. In contrast, when all three
proteins were present, both myopodin and 14-3-3  could be
eluted together with importin  , but not with GST alone (Fig. 3
D, right). These results confirm that 14-3-3 cannot directly bind
to importin  , as expected from the absence of a functional NLS
(Brunet et al., 2002). Furthermore, the direct binding of purified
Figure 3. 14-3-3 binding to myopodin is required for the interac-
tion between myopodin and importin  . (A) Endogenous 14-3-3 
from C2C12 myoblasts coimmmunoprecipitates with myopodin
(FLAG-full-length). FLAG– 14-3-3#1 and FLAG– 14-3-3#2 show
impaired binding to 14-3-3 . No binding to 14-3-3  is found for
FLAG– 14-3-3#1   2. In contrast, deletion of one or both NLSs
(FLAG- NLS#1, FLAG- NLS#2, and FLAG- NLS#1   2) does
not interfere with the binding of myopodin to 14-3-3 . Com-
bined deletion of all four motifs (FLAG– 14-3-3#1   2   
 NLS#1   2) abrogates the binding of myopodin to 14-3-3 .
(B) Binding of 14-3-3  (top) and importin   (middle) to FLAG-
tagged myopodin (bottom). Single NLS deletions (FLAG- NLS#1
and FLAG- NLS#2) do not impair the expression of myopodin or
the interaction of myopodin with 14-3-3  or importin  . In con-
trast, the absence of both NLSs (FLAG- NLS#1   2) causes loss
of importin   binding, whereas 14-3-3  binding is preserved.
Deletion of 14-3-3–binding motifs in myopodin (FLAG– 14-3-3#1,
FLAG– 14-3-3#2, and FLAG– 14-3-3#1   2) abrogates the
interaction of myopodin with 14-3-3  and with importin  . (C) The 14-3-3 inhibitory peptide R18 abrogates the binding of myopodin to 14-3-3  (top) and
to importin   (bottom). (D) Immobilized GST–importin  , but not GST alone, binds purified FLAG-myopodin in the presence of purified FLAG–14-3-3 .
In contrast, no interaction is found between GST–importin   and FLAG–14-3-3  or FLAG-myopodin alone.JCB • VOLUME 169 • NUMBER 3 • 2005 420
myopodin to importin   only occurs in the presence of 14-3-3.
Finally, these results demonstrate that the interaction between
14-3-3  and importin   is indirect and is mediated by myopodin.
Myopodin is phosphorylated in vivo
14-3-3 proteins are phosphoserine/threonine-binding proteins
(Muslin et al., 1996), and many 14-3-3 interactions depend on
the phosphorylation of the target protein (Yaffe, 2002). There-
fore, we examined whether the myopodin–14-3-3 interaction is
regulated by phosphorylation. To this end, purified FLAG-
myopodin was dephosphorylated with   protein phosphatase
( -PPase), which reduced the molecular size of myopodin (Fig.
4 A). Moreover,  -PPase treatment converted the fuzzier signal
of the phosphorylated protein into a more compact and sharper
band (Fig. 4 A, top). These findings show that myopodin is
phosphorylated in vivo.
The binding to 14-3-3  requires the 
phosphorylation of myopodin
Next, we determined whether the phosphorylation of myopodin
is required for binding to 14-3-3  (Fig. 4 B). In the phosphory-
lated state (Fig. 4 B, left), myopodin bound to 14-3-3 , but not
after dephosphorylation with  -PPase (Fig. 4 B, right). This
binding was also abrogated by the 14-3-3 inhibitory peptide
R18 (Fig. 4 B). Therefore, we concluded that the interaction
between myopodin and 14-3-3  is dependent on the phosphor-
ylation of myopodin. To confirm this finding, we analyzed the
ability of dephosphorylated, recombinant myopodin to bind en-
dogenous 14-3-3  from C2C12 myoblasts (Fig. 4 C). FLAG-
tagged myopodin was purified from HEK-293 cells and was in-
cubated with C2C12 protein extract. As shown above for
recombinant proteins (Fig. 2 A), myopodin binds endogenous
14-3-3 , whereas the dephosphorylation with  -PPase abol-
ished the interaction (Fig. 4 C, top). 14-3-3 proteins, including
14-3-3 , can also be phosphorylated (Fu et al., 2000). In a con-
verse experiment, to determine whether the phosphorylation of
14-3-3  is required for myopodin binding, purified FLAG–
14-3-3  was incubated with C2C12 protein extract. 14-3-3 
could bind endogenous myopodin independent of  -PPase
treatment (Fig. 4 C, bottom). This finding is consistent with the
ability of GST–14-3-3  that is purified from bacteria to bind
myopodin (Fig. 1 E). Together, the phosphorylation of myopo-
din is required for 14-3-3 binding, whereas the phosphorylation
of 14-3-3 is not required for myopodin binding.
Dephosphorylation of myopodin 
abrogates importin   binding
To further determine whether the phosphorylation of myopodin is
not only required for 14-3-3 binding but also for importin   bind-
ing, FLAG-tagged myopodin was treated with  -PPase and was
incubated with X. laevis protein extract (Fig. 4 D). In the absence
of  -PPase treatment, FLAG-myopodin bound to 14-3-3  and im-
portin   (Fig. 4 D, left). In contrast, the dephosphorylation of my-
opodin with  -PPase abrogated the interaction with 14-3-3  and
importin   (Fig. 4 D, right). These findings further support the hy-
pothesis that the interaction of myopodin with importin   requires
the phosphorylation-dependent binding of myopodin to 14-3-3.
S225 and T272 mediate the 
phosphorylation-dependent binding of 
myopodin to 14-3-3 
The removal of the 14-3-3–binding sites (Fig. 1 H and Fig. 3, A
and B) and the dephosphorylation of myopodin (Fig. 4, B–D)
abrogate 14-3-3 binding, suggesting that the amino acids
mediating the phosphorylation-dependent interaction are local-
ized within the two 14-3-3–binding motifs. According to the
consensus 14-3-3–binding motifs RSxpS/TxP (mode 1) and
RxxxpS/TxP (mode 2; Yaffe et al., 1997), we predicted that
S225 and T272 were phosphoacceptor sites (Fig. 4 E). To test
Figure 4. Two phosphorylated residues in myopodin mediate 14-3-3
binding. (A) SDS-PAGE analysis showing reduced molecular weight of puri-
fied FLAG-myopodin after dephosphorylation with  -PPase. (B) Dephosphor-
ylation of myopodin abrogates binding to GST–14-3-3 . The interaction is
also prevented by the 14-3-3–blocking peptide R18. (C) Binding of puri-
fied FLAG-myopodin to endogenous 14-3-3  from C2C12 myoblasts is
abrogated by dephosphorylation of myopodin (top). In contrast, binding
of endogenous myopodin to purified FLAG–14-3-3  is not affected by the
dephosphorylation of 14-3-3  (bottom). (D) Dephosphorylation with  -PPase
abrogates the interaction of FLAG-myopodin (bottom) with endogenous
14-3-3  (top) and importin   (middle) from X. laevis extracts. (E) Putative
phosphoacceptor sites within the 14-3-3–binding motifs of myopodin.
S225 in motif#1, as well as T272 and S273 in motif#2, were substituted
with alanine to remove putative phosphorylation sites. Replacement with
aspartic acid or glutamic acid was done to mimic phosphorylation. (F)
Purified FLAG-tagged, wild-type myopodin interacts with GST–14-3-3 .
Substitution  of S225 or T272 with alanine (S225A, T272A, and
S225AT272A) abrogates 14-3-3  binding. Replacement of S273 with
alanine (S273A) does not interfere with the binding of myopodin to 14-3-3 .
(G) Substitutions of S225 or T272 with aspartic or glutamic acid, respec-
tively, does not alter the binding of myopodin to 14-3-3 (top). However,
after dephosphorylation, only S225DT272E retains strong binding to
GST–14-3-3 . Single mutations (S225D and T272E) bind significantly
less, and wild-type binding is abrogated.PROMOTION OF NUCLEAR IMPORT BY 14-3-3 • FAUL ET AL. 421
this hypothesis, we mutated these amino acids to alanine
(S225A and T272A), which cannot be phosphorylated by pro-
tein kinases. As a control, S273, which was not expected to be
crucial for 14-3-3 binding, was also mutated (S273A; Fig. 4 E).
Myopodin and its point mutation variants were expressed as
FLAG fusion proteins in HEK-293 cells and were purified and
incubated with immobilized GST–14-3-3 . Wild-type myopo-
din could bind GST–14-3-3 , whereas no interaction was
found for S225A, T272A, or S225AT272A (Fig. 4 F). In con-
trast, S273A showed normal 14-3-3 binding. As expected from
the single mutation S225A, the combined removal of serine
225 and serine 273 (S225AS273A) also resulted in the loss of
14-3-3 binding (Fig. 4 F). Together, S225 and T272, but not
S273, are crucial for the interaction of myopodin with 14-3-3 .
It also confirms the finding that the two 14-3-3–binding motifs
in myopodin are necessary and sufficient for the efficient inter-
action with 14-3-3  (Fig. 1 H). To determine whether the phos-
phorylation of S225 and T272 is required for 14-3-3 binding,
the phosphorylation of both residues was mimicked by the sub-
stitution of negatively charged amino acids. S225 was replaced
by aspartic acid (S225D) and T272 by glutamic acid (T272E;
Fig. 4 G). The single (S225D and T272E) or combined substi-
tutions (S225DT272E) did not alter binding to GST–14-3-3 
(Fig. 4 G, top). In contrast, after dephosphorylation with
 -PPase and before GST–14-3-3  binding (Fig. 4 G, bottom),
the binding of wild-type myopodin was abrogated, whereas the
binding of S225D and T272E was dramatically reduced. In
contrast, S225DT272E retained strong binding to 14-3-3 ,
demonstrating that the phosphorylation of S225 and S272 is
necessary for the efficient binding of myopodin to 14-3-3 .
S225 and T272 mediate the 
phosphorylation-dependent nuclear 
import of myopodin
To determine whether the aa S225 and T272 of myopodin are
not only required for 14-3-3 binding but are also required for
the nuclear import of myopodin, the subcellular distribution of
GFP-tagged wild-type and mutant myopodin was analyzed by
confocal microscopy (Fig. 5 A) and was quantified as de-
scribed above (Fig. 2 C). As shown previously (Fig. 2 B; Weins
et al., 2001), wild-type myopodin was mainly localized in the
nucleus (Fig. 5 A). The quantitative analysis showed 77.4% nu-
clear localization (Fig. 5 B). The removal of single phosphory-
lation sites (S225A and T272A) resulted in a significantly de-
creased nuclear localization (20.1% for S225A and 20.5% for
T272A; Fig. 5 B) versus 77.4% for wild-type myopodin (P  
0.01; t test). The combined replacement of S225 and T272 (Fig.
5 A, S225AT272A) further decreased nuclear myopodin to
10.5% (Fig. 5 B), a significant difference from the single
mutations S225A and T272A (P   0.01; t test). In contrast,
S273A showed normal nuclear localization (78.8% nuclear;
Fig. 5 B). The active mutants S225D, T272E, or S273D
showed 75.6%, 80.3%, and 75.7% nuclear localization, respec-
tively. The highest percentage of nuclear myopodin was found
for S225DT272E (Fig. 5 A). However, the difference to wild
type (83.5% for S225DT272E versus 77.4% for wild-type myop-
odin) was not significant. Altogether, these experiments show
that the phosphorylation of S225 and T272 is required for the ef-
ficient nuclear import of myopodin.
Discussion
This study uncovered a novel mechanism for the phosphoryla-
tion-dependent nuclear import of NLS-containing proteins. To
the best of our knowledge, this is the first study to demonstrate
that 14-3-3 promotes the nuclear import of a cargo protein. In
particular, we established that phosphorylated myopodin di-
rectly interacts with 14-3-3 proteins, and that this interaction is
functionally significant because it promotes the binding of my-
opodin to importin   and, thereby, promotes the nuclear import
of myopodin.
Nuclear import is regulated at several levels. The binding
of NLS-containing proteins to cytosolic receptors of the impor-
tin/karyopherin superfamily is critical because the affinity of
this interaction determines transport efficiency (Weis, 2003).
Therefore, targeting sequence recognition is a key control point
in the regulation of nuclear import (Jans et al., 2000). One way
to regulate nuclear transport is by changing the phosphoryla-
tion status of the cargo protein. Phosphorylation of the SV40
large tumor antigen and the Drosophila melanogaster morpho-
gen dorsal upstream of the NLSs directly enhances the affinity
between NLSs and importin  / 1 (Hubner et al., 1997; Briggs
Figure 5. Two phosphorylated residues regu-
late nuclear localization of myopodin. (A) Con-
focal imaging of GFP-tagged myopodin in
C2C12 myoblasts. Wild-type myopodin shows
a predominantly nuclear localization (top), and
S225AT272A displays a dramatically de-
creased nuclear localization (middle). In con-
trast, S225DT272E shows a primarily nuclear
localization (bottom). Rhodamine-labeled
phalloidin identifies myopodin-induced actin
bundles, and DAPI visualizes nuclei. (B) Quan-
titative analysis is presented as a percentage of
nuclear GFP–myopodin. 77.4% of wild-type
myopodin is detected in the nucleus. S225A
and T272A show 20.1% and 20.5% nuclear
myopodin, respectively. S225AT272A shows
a further decrease to 10.5%. In contrast,
S273A does not alter nuclear localization (78.8%). S225D, S273D, and T272E show 75.6%, 75.7%, and 80.3% nuclear localization, respectively.
S225DT272E displays 83.5% nuclear localization. Statistical significance was confirmed by ANOVA (P   0.001). Error bars indicate standard deviation.JCB • VOLUME 169 • NUMBER 3 • 2005 422
et al., 1998). The deletion of the phosphorylation sites in these
nuclear cargoes causes a decreased nuclear import rate, which
reveals the importance of serine/threonine phosphorylation for
nuclear import efficiency. Phosphorylation of a cargo protein
may modulate the affinity between NLS and importin   or may
cause a conformational change in the cargo, thereby exposing
an NLS (Harreman et al., 2004). In addition, phosphorylation
may cause the release or binding of a heterologous, NLS-
masking protein.
Recent proteomic analyses of 14-3-3–binding proteins re-
vealed that importins were putative 14-3-3 targets (Meek et al.,
2004). However, 14-3-3 proteins do not have an intrinsic NLS,
and, therefore, the direct binding of importins to 14-3-3 is un-
likely (Brunet et al., 2002). Instead, these interactions are indi-
rect and are mediated by proteins like myopodin that bind both
14-3-3 proteins and importin   (Fig. 3 D).
14-3-3 proteins are highly acidic, chaperone-like mole-
cules that can induce conformational changes in their binding
partners. Myopodin, on the other hand, is a very basic protein
with an isolectric point of 9.34 (Weins et al., 2001). Hence, it
seems conceivable that 14-3-3 binding neutralizes the negative
charge of myopodin. This, in turn, may change the structure of
myopodin, thereby unmasking and exposing NLSs. In this
study, we have shown that myopodin contains two functional
14-3-3–binding sites that are required for efficient 14-3-3 bind-
ing (Fig. 1 H). Because each monomer of a 14-3-3 dimer binds
its target in opposite directions (Yaffe et al., 1997), the binding
of a 14-3-3 dimer could change the predicted linear structure of
myopodin (Weins et al., 2001) to a U-shaped conformation.
This is a potential regulatory conformational change in myopo-
din that could alter its biochemical features, such as the capa-
bility to interact with other proteins (e.g., importin  ). Clearly,
structural analysis of the myopodin–14-3-3 interaction will be
required to confirm or refute this hypothesis.
14-3-3 proteins can participate in protein translocation
into mitochondria (Alam et al., 1994) and chloroplasts (May
and Soll, 2000) by serving as cytoplasmic chaperones. In this
study, we describe a novel role of 14-3-3 as a regulator of nu-
clear import by showing that 14-3-3 binding enables myopodin
to interact with importin  . Protein import into mitochondria
and chloroplasts is mechanistically and evolutionary very dif-
ferent from nuclear import. Nevertheless, the results of this
study suggest that cargoes with different subcellular destina-
tions may share 14-3-3 as a cytoplasmic chaperone in order to
achieve an import-compatible structure.
14-3-3 proteins are involved in the regulation of cell pro-
liferation, differentiation, and cell death (van Hemert et al.,
2001). For example, the epithelial 14-3-3 isoform   serves as a
tumor suppressor (Hermeking, 2003), and the loss of 14-3-3 
expression can cause cell transformation (Dellambra et al.,
2000). Several studies have shown a decrease or loss of 14-3-3 
expression in transformed cells (Simooka et al., 2004; Urano et
al., 2004), including transitional urinary bladder carcinomas
(Ostergaard et al., 1997; Moreira et al., 2004). Myopodin not
only binds to 14-3-3  but also acts as a tumor suppressor in
bladder carcinomas (Sanchez-Carbayo et al., 2003). In fact, the
relocalization of myopodin from the nucleus to the cytoplasm
predicts the clinical outcome of these tumors (Sanchez-Car-
bayo et al., 2003). Based on the results of this study, it is tempt-
ing to speculate that the loss of nuclear myopodin in invasive
bladder tumors results from the loss of 14-3-3  expression or
from the loss of myopodin phosphorylation, which, in turn, ab-
rogates 14-3-3 and importin   binding. Future studies will ex-
plore the phosphorylation stage of myopodin in normal urothe-
lium and in bladder tumors.
To summarize, this study has helped to identify a func-
tional role for 14-3-3 in promoting nuclear import. In particu-
lar, we have shown that importin   binding and the subsequent
nuclear import of the tumor suppressor myopodin are regulated
by the serine/threonine phosphorylation-dependent binding of
myopodin to 14-3-3 (Fig. 6). Altogether, these data provide a
novel paradigm for the regulation of nuclear import by 14-3-3
in that 14-3-3 regulates the binding of a phosphorylated cargo
protein to importin   and the nuclear import machinery.
Materials and methods
Yeast two-hybrid screen
The mouse myopodin fragment Myo-2 (nt 559–1260) that was fused to the
GAL4 DNA-binding domain was used to screen a pretransformed mouse
embryonic (E17.5) cDNA library according to the manufacturer’s protocol
(MATCHMAKER Two-Hybrid System 3; CLONTECH Laboratories, Inc.).
Cloning and vectors
All cDNA fragments used in this study were amplified by RT-PCR using Pfu
DNA polymerase (Stratagene) and were cloned into pEGFP-N1 (CLON-
TECH Laboratories, Inc.), pFLAG-cytomegalo virus-5a, b, and c (Sigma-
Aldrich), or a modified glutathione S-transferase fusion vector (pGEX; Ron
and Dressler, 1992), which was provided by Ben Margolis (University of
Michigan Medical School, Ann Arbor, MI). Point mutations were gener-
ated with the QuikChange Multi Site-Directed Mutagenesis Kit (Strat-
agene). All constructs were verified by DNA sequencing. Mouse myopodin
cDNA and its mutated variants were cloned into pEGFP-N1 and pFLAG
vectors. GST–14-3-3 ,  , and   cDNAs were provided by Andrey Shaw
(Washington University School of Medicine, St. Louis, MO), and GST–14-
3-3  K49E,  ,  ,  , and   were provided by Michael Yaffe (Massachusetts
Institute of Technology, Cambridge, MA). The 14-3-3  cDNA and the
NH2-terminal deletion mutant   N (aa 128–246) were subcloned into
pEGFP-N1, pFLAG, and pGEX. The X. laevis importin  -1a cDNA (pro-
vided by Ian Mattaj, European Molecular Biology Laboratory, Heidelberg,
Figure 6. A model for phosphorylation- and 14-3-3-dependent nuclear
import of myopodin. (1) When phosphoacceptor sites in 14-3-3–binding
motifs#1 (S225) and #2 (T272) are not phosphorylated, myopodin can-
not interact with 14-3-3. Therefore, the NLSs in myopodin are not accessi-
ble for importin   binding, and myopodin cannot enter the nucleus. (2) After
phosphorylation by serine/threonine protein kinases, myopodin binds to
14-3-3, rendering the NLSs accessible for importin   binding. (3) Importin  
binds to the NLSs and mediates the nuclear import of myopodin (4).PROMOTION OF NUCLEAR IMPORT BY 14-3-3 • FAUL ET AL. 423
Germany) was cloned into pGEX. The GFP–C19 construct was provided
by Ganjam Kalpana (Albert Einstein College of Medicine, Bronx, NY).
Antibodies
Rabbit antimyopodin (Weins et al., 2001) and rabbit anti–X. laevis impor-
tin   (Hachet et al., 2004) have been previously described. Rabbit anti–
14-3-3  (C-20) was purchased from Santa Cruz Biotechnology, Inc.; the
mouse monoclonal anti– -actinin antibody (sarcomeric, clone EA-53) was
purchased from Sigma-Aldrich; and the goat anti-GST was purchased
from Amersham Biosciences. HRP-coupled secondary antibodies were
purchased from Promega. For immunofluorescence, Texas red–conju-
gated goat anti–rabbit (Jackson ImmunoResearch Laboratories) and
AlexaFluor488 (Molecular Probes) or Cy3-conjugated goat anti–mouse
(Jackson ImmunoResearch Laboratories) were used. For immunoprecipita-
tion of FLAG fusion proteins, monoclonal anti–FLAG-M2 antibody that was
covalently attached to agarose (Sigma-Aldrich) was used. GFP fusion pro-
teins were detected with rabbit anti-GFP (Living Colors A.v. peptide anti-
body; CLONTECH Laboratories, Inc.), and FLAG fusion proteins were de-
tected with anti–FLAG-M2 antibody.
Cell culture and transfection
Cell culture of C2C12 myoblasts and HEK-293 cells as well as heat shock
were performed as described previously (Weins et al., 2001). For bio-
chemical analyses, transient transfections were performed using Lipo-
fectamin2000 (Invitrogen).
Immunofluorescence and confocal microscopy
Immunofluorescence microscopy was performed as described previously
(Weins et al., 2001). Anti–14-3-3  was used at 1:50; anti– -actinin was
used at 1:1,000; rhodamine-labeled phalloidin (Molecular Probes) was
used at 1:500; and DAPI was used at 1:5,000.
Quantification of nuclear myopodin
We used a high resolution Nomarski objective (60 , NA 1.4; Olympus)
and a high resolution epifluorescence with a precision stepper motor
(model 99S001; Ludl) to measure the depth of individual cells. The adher-
ent cells ranged from 5 to 8  m in depth. The plasma membrane was
stretched tightly over the top and bottom of the nuclei in these cells, and
the nucleus appeared to span the entire depth of the cell. For the quantita-
tive analysis of the localization of GFP fusion proteins, phase-contrast im-
ages of transfected myoblasts were collected. Using a widefield micro-
scope system (model IX70; Olympus), the axial depth that was detected
was deeper than 5  m, and, therefore, fluorescence was accurately de-
tected from the entire depth of the cells. To analyze transfected cells,
whole cell areas, nuclei, and backgrounds of 25 cells per construct were
traced using IPLab Image Analysis software (Scanalytics). For further calcu-
lations, Excel software (Microsoft) was used. The mean background level
was subtracted from the means of the entire cell and the nucleus alone. To
determine the content of GFP fusion protein in the whole cell versus that in
the nucleus, the mean intensity of the entire cell versus the nucleus was
multiplied by the area of each. Total GFP fusion protein in the cytoplasm
was calculated by subtracting the mass of the nucleus from the mass of the
total cell. The percentage of nuclear myopodin was calculated by dividing
the mass of the nucleus by the mass of the cytoplasm.
Tissue and cell lysates
GST pull-down experiments were performed as described previously
(Schwarz et al., 2001). For coimmunoprecipitation of endogenous pro-
teins from the mouse heart, the tissue was homogenized in extraction
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% deoxy-
cholic acid, and 1% NP-40) in a 1:3 wt/vol ratio. To purify FLAG-tagged
proteins, HEK-293 cells were cultured in a 10-cm dish to  90% conflu-
ence and were transfected with FLAG cDNA constructs. After 24 h, cells
were washed with PBS and were harvested with a cell scraper in 900  l
of modified radioimmunoprecipitation buffer (40 mM Tris, pH 7.4, 200
mM NaCl, 1% Triton X-100, 0.25% deoxycholic acid, 1 mM EDTA, and 1
mM EGTA). Lysates were incubated on ice for 30 min and were cleared at
14,000 g for 15 min at 4 C. For coimmunoprecipitation of FLAG- or GFP-
tagged fusion proteins, HEK-293 cells were grown on a 10-cm dish, were
cotransfected at a confluence of  90%, and were harvested on ice after
24 h using 5 ml PBS/50 mM EDTA. Cells were pelleted using centrifuga-
tion at 1,000 g for 5 min at 4 C and were washed twice with 5 ml PBS.
For cell lysis, the pellet was resuspended in 1 ml of immunoprecipitation
(IP) buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 50 mM KCl, 10 mM
EDTA, 10 mM EGTA, 1.5% Triton X-100, and 0.75% NP-40) and was in-
cubated on ice for 30 min. The cell lysate was cleared by centrifugation
for 10 min at 5,000 g. To coimmunoprecipitate endogenous 14-3-3  from
myoblasts, C2C12 cells were grown on a 10-cm dish and were trans-
fected with FLAG constructs at a confluence of  90%. FLAG fusion pro-
teins were isolated as described for HEK-293 cells. For X. laevis protein
extracts, 100 2-d-old embryos were homogenized in 2 ml IP buffer. After
centrifuging at 10,000 g for 30 min at 4 C, the supernatant was used for
binding studies.
Western blotting and endogenous coimmunoprecipitation
SDS-PAGE and Western blotting were performed as described previously
(Mundel et al., 1997; Weins et al., 2001). Antibodies were used at the
following ratios: myopodin-specific antibody SRIB2 at 1:300; anti–14-3-3 
antibody at 1:2,000; anti–importin   antibody at 1:1,000; antibody
against FLAG at 1:10,000; antibody against GFP at 1:300; anti-GST at
1:10,000; and HRP-conjugated secondary antibodies at 1:20,000. The
immunoreaction was visualized by ECL (Amersham Biosciences). To immu-
noprecipitate endogenous protein complexes, 1 ml of mouse heart extract
was incubated overnight with 2  g of antibodies at 4 C under rotation.
Immune complexes were precipitated with 50  l of protein A/G–Sepha-
rose (Sigma-Aldrich) and were eluted in 100  l SDS sample buffer. Anti-
GFP IgG served as a negative control.
GST-binding assays
GST pull-down studies from tissue and cell extracts were performed as re-
ported previously (Schwarz et al., 2001). To study the interaction between
GST fusion proteins and FLAG-tagged proteins, GST proteins were ex-
pressed in bacteria and were purified using glutathione-coupled agarose
as described previously (Schwarz et al., 2001). 1  g of purified FLAG fu-
sion protein in 500  l PBS was added to the glutathione beads, and the
reaction was incubated at 4 C under rotation for 2 h. For 14-3-3 inhibition
studies, 1 mM R18 peptide (provided by Thomas McDonald, Albert Ein-
stein College of Medicine; Wang et al., 1999) was added to the FLAG fu-
sion protein in PBS. For the triple binding assay with purified importin  ,
myopodin, and 14-3-3 , the immobilized GST fusion protein was incu-
bated with 1  g each of two purified FLAG proteins. Silver staining and
Western blot analysis confirmed the purity of FLAG-tagged myopodin
and FLAG-tagged 14-3-3 . The beads were collected by centrifugation
and were washed five times in 1 ml PBS, and bound proteins were eluted
by boiling in 150  l Laemmli buffer. Eluates were analyzed by SDS-PAGE
and by immunoblotting.
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